Published in BMC Bioinformatics on September 10, 2008
Pathogen chip for respiratory tract infections. J Clin Microbiol (2013) 0.85
Large-scale evolutionary surveillance of the 2009 H1N1 influenza A virus using resequencing arrays. Nucleic Acids Res (2010) 0.85
Expression monitoring by hybridization to high-density oligonucleotide arrays. Nat Biotechnol (1996) 72.84
Microarray-based detection and genotyping of viral pathogens. Proc Natl Acad Sci U S A (2002) 7.27
Improved nearest-neighbor parameters for predicting DNA duplex stability. Biochemistry (1996) 6.68
Pitfalls of quantitative real-time reverse-transcription polymerase chain reaction. J Biomol Tech (2004) 5.97
Viral discovery and sequence recovery using DNA microarrays. PLoS Biol (2003) 5.95
Role of deficient type III interferon-lambda production in asthma exacerbations. Nat Med (2006) 5.90
A rapid method for detecting and mapping homology between heterologous DNAs. Evaluation of polyomavirus genomes. J Biol Chem (1979) 5.32
RNA viral community in human feces: prevalence of plant pathogenic viruses. PLoS Biol (2006) 4.93
Gene expression analysis using oligonucleotide arrays produced by maskless photolithography. Genome Res (2002) 4.69
Genomic DNA amplification from a single bacterium. Appl Environ Microbiol (2005) 4.25
A method for the rapid sequence-independent amplification of microdissected chromosomal material. Genomics (1992) 2.93
Options available--from start to finish--for obtaining data from DNA microarrays II. Nat Genet (2002) 2.62
Respiratory syncytial virus infection: denominator-based studies in Indonesia, Mozambique, Nigeria and South Africa. Bull World Health Organ (2005) 2.50
Tracking the evolution of the SARS coronavirus using high-throughput, high-density resequencing arrays. Genome Res (2004) 2.47
A novel pancoronavirus RT-PCR assay: frequent detection of human coronavirus NL63 in children hospitalized with respiratory tract infections in Belgium. BMC Infect Dis (2005) 2.28
Simultaneous detection, subgrouping, and quantitation of respiratory syncytial virus A and B by real-time PCR. J Clin Microbiol (2003) 1.96
Options available for profiling small samples: a review of sample amplification technology when combined with microarray profiling. Nucleic Acids Res (2006) 1.74
PCR amplification of megabase DNA with tagged random primers (T-PCR). Nucleic Acids Res (1993) 1.69
Multiplex real time RT-PCR for the detection and quantitation of norovirus genogroups I and II in patients with acute gastroenteritis. J Clin Virol (2005) 1.64
Detection of respiratory viruses and subtype identification of influenza A viruses by GreeneChipResp oligonucleotide microarray. J Clin Microbiol (2007) 1.59
Microarray analysis of evolution of RNA viruses: evidence of circulation of virulent highly divergent vaccine-derived polioviruses. Proc Natl Acad Sci U S A (2003) 1.33
Robust sequence selection method used to develop the FluChip diagnostic microarray for influenza virus. J Clin Microbiol (2006) 1.25
Optimization and clinical validation of a pathogen detection microarray. Genome Biol (2007) 1.18
A colorimetric microtiter plate PCR system detects respiratory syncytial virus in nasal aspirates and discriminates subtypes A and B. Diagn Microbiol Infect Dis (1999) 1.11
Minimising the secondary structure of DNA targets by incorporation of a modified deoxynucleoside: implications for nucleic acid analysis by hybridisation. Nucleic Acids Res (2000) 1.07
Molecular approaches to detecting herpes simplex virus and enteroviruses in the central nervous system. J Clin Microbiol (2002) 1.04
Design of microarray probes for virus identification and detection of emerging viruses at the genus level. BMC Bioinformatics (2006) 1.00
Generation of non-genomic oligonucleotide tag sequences for RNA template-specific PCR. BMC Biotechnol (2006) 1.00
Fast and accurate probe selection algorithm for large genomes. Proc IEEE Comput Soc Bioinform Conf (2003) 0.82
High-level multiplex DNA amplification. Antisense Nucleic Acid Drug Dev (2001) 0.82
A global map of p53 transcription-factor binding sites in the human genome. Cell (2006) 20.65
Genetic reclassification of histologic grade delineates new clinical subtypes of breast cancer. Cancer Res (2006) 8.08
Whole-genome cartography of estrogen receptor alpha binding sites. PLoS Genet (2007) 5.85
Discovery of estrogen receptor alpha target genes and response elements in breast tumor cells. Genome Biol (2004) 2.77
Conservation of gene expression signatures between zebrafish and human liver tumors and tumor progression. Nat Biotechnol (2005) 2.51
Tracking the evolution of the SARS coronavirus using high-throughput, high-density resequencing arrays. Genome Res (2004) 2.47
Transcriptome analysis of zebrafish embryogenesis using microarrays. PLoS Genet (2005) 2.32
Identification of cell cycle-regulated genes in fission yeast. Mol Biol Cell (2004) 2.29
Sall4 regulates distinct transcription circuitries in different blastocyst-derived stem cell lineages. Cell Stem Cell (2008) 2.28
Targeting aldehyde dehydrogenase cancer stem cells in ovarian cancer. Mol Cancer Ther (2010) 2.27
Prospective molecular profiling of melanoma metastases suggests classifiers of immune responsiveness. Cancer Res (2002) 2.21
Whole-genome sequencing identifies recurrent mutations in hepatocellular carcinoma. Genome Res (2013) 2.12
Gene expression preferentially regulated by tamoxifen in breast cancer cells and correlations with clinical outcome. Cancer Res (2006) 2.02
Ferroportin and iron regulation in breast cancer progression and prognosis. Sci Transl Med (2010) 1.94
Correlation test to assess low-level processing of high-density oligonucleotide microarray data. BMC Bioinformatics (2005) 1.86
Oseltamivir ring prophylaxis for containment of 2009 H1N1 influenza outbreaks. N Engl J Med (2010) 1.79
RCP is a human breast cancer-promoting gene with Ras-activating function. J Clin Invest (2009) 1.71
Sal-like protein 4 (SALL4), a stem cell biomarker in liver cancers. Hepatology (2013) 1.63
CDKN1C (p57) is a direct target of EZH2 and suppressed by multiple epigenetic mechanisms in breast cancer cells. PLoS One (2009) 1.52
CT-X antigen expression in human breast cancer. Proc Natl Acad Sci U S A (2009) 1.51
AP-2γ regulates oestrogen receptor-mediated long-range chromatin interaction and gene transcription. EMBO J (2011) 1.49
Molecular changes from dysplastic nodule to hepatocellular carcinoma through gene expression profiling. Hepatology (2005) 1.48
Genomic profiles specific to patient ethnicity in lung adenocarcinoma. Clin Cancer Res (2011) 1.45
Laboratory-acquired severe acute respiratory syndrome. N Engl J Med (2004) 1.37
Transcriptional regulation of mitotic genes by camptothecin-induced DNA damage: microarray analysis of dose- and time-dependent effects. Cancer Res (2002) 1.34
Positive cross-talk between estrogen receptor and NF-kappaB in breast cancer. Cancer Res (2009) 1.32
Interactions between immunity, proliferation and molecular subtype in breast cancer prognosis. Genome Biol (2013) 1.26
Optimization and clinical validation of a pathogen detection microarray. Genome Biol (2007) 1.18
Multiplatform genome-wide identification and modeling of functional human estrogen receptor binding sites. Genome Biol (2006) 1.17
In the pursuit of complexity: systems medicine in cancer biology. Cancer Cell (2006) 1.15
Neurotensin receptor 1 determines the outcome of non-small cell lung cancer. Clin Cancer Res (2010) 1.14
Inhibitory effects of estrogen receptor beta on specific hormone-responsive gene expression and association with disease outcome in primary breast cancer. Breast Cancer Res (2007) 1.11
Prediction of clinical outcome in multiple lung cancer cohorts by integrative genomics: implications for chemotherapy selection. Cancer Res (2009) 1.10
A modular analysis of breast cancer reveals a novel low-grade molecular signature in estrogen receptor-positive tumors. Clin Cancer Res (2006) 1.09
Large-scale functional organization of long-range chromatin interaction networks. Cell Rep (2012) 1.08
Identification of white spot syndrome virus latency-related genes in specific-pathogen-free shrimps by use of a microarray. J Virol (2003) 1.08
Hormone-replacement therapy influences gene expression profiles and is associated with breast-cancer prognosis: a cohort study. BMC Med (2006) 1.08
Functional analysis of a cell cycle-associated, tumor-suppressive gene, protein tyrosine phosphatase receptor type G, in nasopharyngeal carcinoma. Cancer Res (2008) 1.07
YB-1, the E2F pathway, and regulation of tumor cell growth. J Natl Cancer Inst (2011) 1.04
Deletion of the WD40 domain of LRRK2 in Zebrafish causes Parkinsonism-like loss of neurons and locomotive defect. PLoS Genet (2010) 1.03
Cyclin E2 overexpression is associated with endocrine resistance but not insensitivity to CDK2 inhibition in human breast cancer cells. Mol Cancer Ther (2012) 1.01
RAS Mutations and Oncogenesis: Not all RAS Mutations are Created Equally. Front Genet (2012) 0.99
The regulation of SOX7 and its tumor suppressive role in breast cancer. Am J Pathol (2013) 0.99
Yin Yang 1 plays an essential role in breast cancer and negatively regulates p27. Am J Pathol (2012) 0.98
DEAD-box helicase DP103 defines metastatic potential of human breast cancers. J Clin Invest (2014) 0.97
Yin Yang 1 contains G-quadruplex structures in its promoter and 5'-UTR and its expression is modulated by G4 resolvase 1. Nucleic Acids Res (2011) 0.97
Emergence of oseltamivir-resistant pandemic (H1N1) 2009 virus within 48 hours. Emerg Infect Dis (2010) 0.96
Rapid apoptosis in the pulmonary vasculature distinguishes non-metastatic from metastatic melanoma cells. Cancer Lett (2004) 0.94
IRP2 regulates breast tumor growth. Cancer Res (2013) 0.94
Trefoil factor 3 is oncogenic and mediates anti-estrogen resistance in human mammary carcinoma. Neoplasia (2010) 0.94
Transcriptome kinetics of arsenic-induced adaptive response in zebrafish liver. Physiol Genomics (2006) 0.94
SOSTDC1 differentially modulates Smad and beta-catenin activation and is down-regulated in breast cancer. Breast Cancer Res Treat (2010) 0.89
BEARR: Batch Extraction and Analysis of cis-Regulatory Regions. Nucleic Acids Res (2004) 0.88
Pathogen chip for respiratory tract infections. J Clin Microbiol (2013) 0.85
Large-scale evolutionary surveillance of the 2009 H1N1 influenza A virus using resequencing arrays. Nucleic Acids Res (2010) 0.85
Monochromosome transfer and microarray analysis identify a critical tumor-suppressive region mapping to chromosome 13q14 and THSD1 in esophageal carcinoma. Mol Cancer Res (2008) 0.84
Prognostic and predictive immune gene signatures in breast cancer. Curr Opin Oncol (2015) 0.83
Gene expression profiling to identify oncogenic determinants of autocrine human growth hormone in human mammary carcinoma. J Biol Chem (2005) 0.83
Comparison of clinical outcomes and genomic characteristics of single focus and multifocal glioblastoma. J Neurooncol (2014) 0.82
Identifying gene expression changes in breast cancer that distinguish early and late relapse among uncured patients. Bioinformatics (2006) 0.80
Tissue-specific interferon alpha subtype response to SIV infection in brain, spleen, and lung. J Interferon Cytokine Res (2012) 0.80
Investigation of causes of oseltamivir chemoprophylaxis failures during influenza A (H1N1-2009) outbreaks. J Clin Virol (2010) 0.79
A gene signature in breast cancer. N Engl J Med (2007) 0.77
Multidrug-resistant tuberculosis outbreak in gaming centers, Singapore, 2012. Emerg Infect Dis (2015) 0.75
FAMCS: finding all maximal common substructures in proteins. Genomics Proteomics Bioinformatics (2005) 0.75
Spectrum-based de novo repeat detection in genomic sequences. J Comput Biol (2008) 0.75